• 14868 Citations
  • 61 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kyong Soo Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Resistance Medicine & Life Sciences
Glucose Medicine & Life Sciences
Insulin Medicine & Life Sciences
Medical problems Chemical Compounds
Peroxisome Proliferator-Activated Receptors Medicine & Life Sciences
Mitochondrial DNA Medicine & Life Sciences
Obesity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes

Kim, M. J., Kim, M. N., Min, S. H., Ham, D. S., Kim, J. W., Yoon, K. H., Park, K. S. & Jung, H. S., 1 Aug 2019, In : Metabolism: Clinical and Experimental. 97, p. 87-91 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Type 2 Diabetes Mellitus
Insulin
Glucose
glimepiride
Palmitates
4 Citations (Scopus)

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls

Broad Genomics Platform, DiscovEHR Collaboration, CHARGE, LuCamp, ProDiGY, GoT2D, ESP, SIGMA-T2D, T2D-GENES & AMP-T2D-GENES, 6 Jun 2019, In : Nature. 570, 7759, p. 71-76 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Exome
Type 2 Diabetes Mellitus
Genes
Gene Knockout Techniques
Gene Frequency
Phosphodiesterase 3 Inhibitors
Coronary Stenosis
Type 2 Diabetes Mellitus
Coronary Artery Disease
Aspirin

SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle

Koo, Y. D., Lee, J. S., Lee, S. A., Quaresma, P. G. F., Bhat, R., Haynes, W. G., Park, Y. J., Kim, Y. B., Chung, S. S. & Park, K. S., 1 Jun 2019, In : Metabolism: Clinical and Experimental. 95, p. 27-35 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Ubiquitin
Leptin
Skeletal Muscle
Peptide Hydrolases
Fatty Acids
6 Citations (Scopus)

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

SONAR Committees and Investigators, 11 May 2019, In : The Lancet. 393, 10184, p. 1937-1947 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Placebos
Kidney